BTK is mainly expressed in bone marrow–derived cells, and most studies have focused on BTK in terms of lymphoma, though others have suggested that BTK plays a vital role in the oncogenic process of solid tumors, such as colon cancer, ovarian cancer, and glioma [14–16]. The gene discussed is BTK; the disease is ovarian cancer.